BRUKER CORP (BRKR) Stock Fundamental Analysis
NASDAQ:BRKR - Nasdaq - US1167941087 - Common Stock - Currency: USD
BRKR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 55 industry peers in the Life Sciences Tools & Services industry. While BRKR is still in line with the averages on profitability rating, there are concerns on its financial health. BRKR has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
BRKR had positive earnings in the past year.
In the past year BRKR had a positive cash flow from operations.
BRKR had positive earnings in each of the past 5 years.
BRKR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of BRKR (1.34%) is better than 70.91% of its industry peers.
With a decent Return On Equity value of 4.38%, BRKR is doing good in the industry, outperforming 74.55% of the companies in the same industry.
BRKR's Return On Invested Capital of 5.54% is fine compared to the rest of the industry. BRKR outperforms 69.09% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BRKR is below the industry average of 13.60%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.34% | ||
| ROE | 4.38% | ||
| ROIC | 5.54% |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
1.3 Margins
The Profit Margin of BRKR (2.31%) is better than 70.91% of its industry peers.
BRKR's Profit Margin has declined in the last couple of years.
BRKR's Operating Margin of 10.99% is fine compared to the rest of the industry. BRKR outperforms 65.45% of its industry peers.
BRKR's Operating Margin has declined in the last couple of years.
BRKR has a Gross Margin (49.28%) which is in line with its industry peers.
In the last couple of years the Gross Margin of BRKR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.99% | ||
| PM (TTM) | 2.31% | ||
| GM | 49.28% |
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BRKR is destroying value.
Compared to 1 year ago, BRKR has more shares outstanding
The number of shares outstanding for BRKR has been reduced compared to 5 years ago.
BRKR has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.48 indicates that BRKR is not a great score, but indicates only limited risk for bankruptcy at the moment.
BRKR has a Altman-Z score (2.48) which is comparable to the rest of the industry.
BRKR has a debt to FCF ratio of 12.11. This is a negative value and a sign of low solvency as BRKR would need 12.11 years to pay back of all of its debts.
BRKR has a Debt to FCF ratio of 12.11. This is comparable to the rest of the industry: BRKR outperforms 54.55% of its industry peers.
A Debt/Equity ratio of 1.14 is on the high side and indicates that BRKR has dependencies on debt financing.
BRKR has a Debt to Equity ratio of 1.14. This is amonst the worse of the industry: BRKR underperforms 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.14 | ||
| Debt/FCF | 12.11 | ||
| Altman-Z | 2.48 |
ROIC/WACC0.57
WACC9.73%
2.3 Liquidity
A Current Ratio of 1.57 indicates that BRKR should not have too much problems paying its short term obligations.
BRKR has a Current ratio of 1.57. This is in the lower half of the industry: BRKR underperforms 70.91% of its industry peers.
BRKR has a Quick Ratio of 1.57. This is a bad value and indicates that BRKR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of BRKR (0.72) is worse than 89.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.57 | ||
| Quick Ratio | 0.72 |
3. Growth
3.1 Past
BRKR shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.56%.
BRKR shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.95% yearly.
BRKR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.84%.
BRKR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.19% yearly.
EPS 1Y (TTM)-8.56%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-11.32%
Revenue 1Y (TTM)14.84%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%11.04%
3.2 Future
Based on estimates for the next years, BRKR will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.88% on average per year.
The Revenue is expected to grow by 5.08% on average over the next years.
EPS Next Y3.45%
EPS Next 2Y8.4%
EPS Next 3Y10.92%
EPS Next 5Y10.88%
Revenue Next Year4.74%
Revenue Next 2Y4.47%
Revenue Next 3Y4.9%
Revenue Next 5Y5.08%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 18.63, the valuation of BRKR can be described as rather expensive.
BRKR's Price/Earnings ratio is rather cheap when compared to the industry. BRKR is cheaper than 85.45% of the companies in the same industry.
When comparing the Price/Earnings ratio of BRKR to the average of the S&P500 Index (27.30), we can say BRKR is valued slightly cheaper.
The Price/Forward Earnings ratio is 15.46, which indicates a correct valuation of BRKR.
Based on the Price/Forward Earnings ratio, BRKR is valued cheaply inside the industry as 89.09% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of BRKR to the average of the S&P500 Index (21.76), we can say BRKR is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.63 | ||
| Fwd PE | 15.46 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BRKR indicates a rather cheap valuation: BRKR is cheaper than 85.45% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, BRKR is valued a bit cheaper than the industry average as 63.64% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 38 | ||
| EV/EBITDA | 14.76 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BRKR does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)5.4
PEG (5Y)2.08
EPS Next 2Y8.4%
EPS Next 3Y10.92%
5. Dividend
5.1 Amount
With a yearly dividend of 0.46%, BRKR is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.50, BRKR pays a better dividend. On top of this BRKR pays more dividend than 90.91% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.37, BRKR's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.46% |
5.2 History
The dividend of BRKR has a limited annual growth rate of 4.81%.
BRKR has paid a dividend for at least 10 years, which is a reliable track record.
BRKR has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)4.81%
Div Incr Years0
Div Non Decr Years8
5.3 Sustainability
38.44% of the earnings are spent on dividend by BRKR. This is a low number and sustainable payout ratio.
The dividend of BRKR is growing, but earnings are growing more, so the dividend growth is sustainable.
DP38.44%
EPS Next 2Y8.4%
EPS Next 3Y10.92%
43.79
+0.21 (+0.48%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners82.12%
Inst Owner Change0%
Ins Owners26.98%
Ins Owner Change0.13%
Market Cap6.64B
Analysts76.19
Price Target54.97 (25.53%)
Short Float %9.59%
Short Ratio4.15
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.46% |
Yearly Dividend0.2
Dividend Growth(5Y)4.81%
DP38.44%
Div Incr Years0
Div Non Decr Years8
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.87%
Min EPS beat(2)1.16%
Max EPS beat(2)6.57%
EPS beat(4)2
Avg EPS beat(4)1.06%
Min EPS beat(4)-2.58%
Max EPS beat(4)6.57%
EPS beat(8)6
Avg EPS beat(8)5.91%
EPS beat(12)9
Avg EPS beat(12)6.53%
EPS beat(16)12
Avg EPS beat(16)9.18%
Revenue beat(2)1
Avg Revenue beat(2)1.07%
Min Revenue beat(2)-0.62%
Max Revenue beat(2)2.76%
Revenue beat(4)1
Avg Revenue beat(4)-0.17%
Min Revenue beat(4)-1.45%
Max Revenue beat(4)2.76%
Revenue beat(8)4
Avg Revenue beat(8)0.64%
Revenue beat(12)7
Avg Revenue beat(12)1.07%
Revenue beat(16)11
Avg Revenue beat(16)1.46%
PT rev (1m)-7.78%
PT rev (3m)-18.67%
EPS NQ rev (1m)0.55%
EPS NQ rev (3m)-22.48%
EPS NY rev (1m)-0.8%
EPS NY rev (3m)-8.16%
Revenue NQ rev (1m)-0.12%
Revenue NQ rev (3m)-2.37%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.63 | ||
| Fwd PE | 15.46 | ||
| P/S | 1.93 | ||
| P/FCF | 38 | ||
| P/OCF | 22.53 | ||
| P/B | 3.65 | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.76 |
EPS(TTM)2.35
EY5.37%
EPS(NY)2.83
Fwd EY6.47%
FCF(TTM)1.15
FCFY2.63%
OCF(TTM)1.94
OCFY4.44%
SpS22.74
BVpS11.99
TBVpS-4.07
PEG (NY)5.4
PEG (5Y)2.08
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.34% | ||
| ROE | 4.38% | ||
| ROCE | 8.25% | ||
| ROIC | 5.54% | ||
| ROICexc | 5.77% | ||
| ROICexgc | 12.9% | ||
| OM | 10.99% | ||
| PM (TTM) | 2.31% | ||
| GM | 49.28% | ||
| FCFM | 5.07% |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
ROICexc(3y)11.26%
ROICexc(5y)12.82%
ROICexgc(3y)18.89%
ROICexgc(5y)20.78%
ROCE(3y)13.86%
ROCE(5y)13.83%
ROICexcg growth 3Y-22.35%
ROICexcg growth 5Y-9.61%
ROICexc growth 3Y-31.42%
ROICexc growth 5Y-15.9%
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
F-Score3
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.14 | ||
| Debt/FCF | 12.11 | ||
| Debt/EBITDA | 3.59 | ||
| Cap/Depr | 60.1% | ||
| Cap/Sales | 3.48% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 50.93% | ||
| Profit Quality | 219.35% | ||
| Current Ratio | 1.57 | ||
| Quick Ratio | 0.72 | ||
| Altman-Z | 2.48 |
F-Score3
WACC9.73%
ROIC/WACC0.57
Cap/Depr(3y)100.42%
Cap/Depr(5y)105.08%
Cap/Sales(3y)4.05%
Cap/Sales(5y)4.17%
Profit Quality(3y)75.38%
Profit Quality(5y)88.75%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.56%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-11.32%
EPS Next Y3.45%
EPS Next 2Y8.4%
EPS Next 3Y10.92%
EPS Next 5Y10.88%
Revenue 1Y (TTM)14.84%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%11.04%
Revenue Next Year4.74%
Revenue Next 2Y4.47%
Revenue Next 3Y4.9%
Revenue Next 5Y5.08%
EBIT growth 1Y-13.58%
EBIT growth 3Y-3.19%
EBIT growth 5Y4.86%
EBIT Next Year29.66%
EBIT Next 3Y16.46%
EBIT Next 5Y14.77%
FCF growth 1Y17.26%
FCF growth 3Y-10.61%
FCF growth 5Y-0.63%
OCF growth 1Y3.66%
OCF growth 3Y-3.81%
OCF growth 5Y3.32%